VRNT(VRNT)
VRNT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $1.01B | $1.10B | $1.18B | $1.27B |
| Low | $1.00B | $1.06B | $1.16B | $1.25B |
| High | $1.02B | $1.13B | $1.19B | $1.28B |
| EBITDA Avg | $138M | $150M | $160M | $172M |
| Low | $137M | $145M | $158M | $170M |
| High | $140M | $154M | $163M | $175M |
| EBIT Avg | $65M | $70M | $75M | $81M |
| Low | $64M | $68M | $74M | $80M |
| High | $65M | $72M | $76M | $82M |
| Net Income Avg | $199M | $228M | $254M | $284M |
| Low | $197M | $224M | $250M | $279M |
| High | $201M | $232M | $259M | $289M |
| EPS Avg | $3.18 | $3.63 | $4.05 | $4.52 |
| Low | $3.14 | $3.57 | $3.99 | $4.45 |
| High | $3.21 | $3.70 | $4.12 | $4.60 |
| Analysts (Rev / EPS) | 3 / 2 | 2 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|
| Revenue Avg | $262M | $310M | $226M | $215M | $277M | $315M |
| Low | $262M | $310M | $226M | $215M | $277M | $315M |
| High | $262M | $310M | $226M | $215M | $277M | $315M |
| EBITDA Avg | $36M | $42M | $31M | $29M | $38M | $43M |
| Low | $36M | $42M | $31M | $29M | $38M | $43M |
| High | $36M | $42M | $31M | $29M | $38M | $43M |
| EBIT Avg | $17M | $20M | $14M | $14M | $18M | $20M |
| Low | $17M | $20M | $14M | $14M | $18M | $20M |
| High | $17M | $20M | $14M | $14M | $18M | $20M |
| Net Income Avg | $49M | $78M | $23M | $21M | $65M | $100M |
| Low | $49M | $78M | $23M | $21M | $65M | $100M |
| High | $49M | $78M | $23M | $21M | $65M | $100M |
| EPS Avg | $0.82 | $1.30 | $0.38 | $0.35 | $1.09 | $1.66 |
| Low | $0.82 | $1.30 | $0.38 | $0.35 | $1.09 | $1.66 |
| High | $0.82 | $1.30 | $0.38 | $0.35 | $1.09 | $1.66 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |